TSXV/EBM (TSXV/EBM)

TSX Venture Exchange: TSXV/EBM · CAD

CA$1.95

-0.04 (-2.0%)· Recorded snapshot

Market cap	134.3M
Revenue (ttm)	812.1K
Net income (ttm)	-231.6K
EPS (ttm)	-CA$0.00
Shares out	68.9M
Volume	1,182
Beta	0.32

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 812.1K
Net income (ttm): -231.6K
EPS (ttm): -CA$0.00
Market cap: 134.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/EBM indicators

Market & fundamental data

Available fields

163

Groups with data

Currency

CAD

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2027-02-26
Enterprise value	CAD 134.4M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-07-31
First seen	2026-05-10
Fiscal year end	October
Founded	2010
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA27783W1059
Last earnings date	2026-02-27
Last refreshed	2026-10-28
Market cap	CAD 134.3M
Next earnings date	2027-02-26
Price	CAD 1.95
Price currency	CAD
Sector	Healthcare
SIC code	5122
Stock price date	2026-10-28
Symbol	tsxv/EBM
Website	https://eleotin.ca

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-0.17%
EV/Sales	168.87x
FCF / EV yield	-0.01%
FCF yield	-0.01%
P/S ratio	168.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-22.03%
EBITDA margin	-18.17%
Gross margin	70.13%
Operating margin	-22.03%
Pretax margin	-28.51%
Profit margin	-28.51%
ROA	-47.2%
ROA (5Y)	-47.96%
ROCE	10.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Gross profit growth	49.89%
Gross profit growth (Q)	-5.58%
Gross profit growth 3Y	-7.2%
Gross profit growth 5Y	14.96%
Net income growth years	2
Revenue growth	36.59%
Revenue growth (Q)	19.4%
Revenue growth (QoQ)	3.32%
Revenue growth 10Y	2.38%
Revenue growth 3Y	-10.15%
Revenue growth 5Y	-2.32%
Revenue growth quarters	2
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 31,361
EBIT	CAD -178,890
EBITDA	CAD -147,529
EPS	CAD -0.00
FCF per share	CAD -0.00
Financing cash flow	CAD -7,688
Free cash flow	CAD -9,428
Gross profit	CAD 569,541
Net borrowing	CAD -7,688
Net cash flow	CAD -17,116
Net income	CAD -231,559
Operating income	CAD -178,890
Revenue	CAD 812,116

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-28.24
Book value per share	CAD -0.03
Interest coverage	-19.87
Long-term assets	CAD 154,289
Long-term liabilities	CAD 0
Net cash (debt)	CAD -60,119
Net cash / market cap	-0.04%
Piotroski F-Score	4
Property, plant and equipment	CAD 154,289
Shareholders' equity	CAD -1.8M
Tangible book value	CAD -1.8M
Tangible book value per share	CAD -0.03
Total assets	CAD 256,960
Total cash	CAD 3,528
Total debt	CAD 63,647
Total liabilities	CAD 2M
WACC	5.99%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	3.43
Current assets	CAD 102,671
Current liabilities	CAD 2M
Current ratio	0.05
Net working capital	CAD -1.9M
Quick ratio	0.05
Working capital	CAD -1.9M
Working capital turnover	-0.44

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	1,279.31%
10Y return CAGR	30.01%
10Y total return	1,279.31%
150-day SMA	CAD 1.20
1D price change	-2.01%
1M price change	9.29%
1M total return	9.29%
1W price change	16.28%
1W total return	16.28%
1Y price change	233.33%
1Y return CAGR	233.61%
1Y total return	233.33%
20-day SMA	CAD 1.89
200-day SMA	CAD 1.11
3M price change	106.19%
3M total return	106.19%
3Y price change	150%
3Y return CAGR	35.71%
3Y total return	150%
50-day SMA	CAD 1.87
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 2.06
52-week high date	2026-10-01
52-week low	CAD 0.49
52-week low date	2026-01-16
5Y price change	36.99%
5Y return CAGR	6.5%
5Y total return	36.99%
6M price change	207.69%
6M total return	207.69%
All-time high	CAD 8.49
All-time high date	2018-09-20
All-time low	CAD 0.06
All-time low date	2017-07-27
Average true range (ATR)	CAD 0.13
Average volume	3.3K
Beta (1Y)	2.54
Beta (2Y)	0.37
Beta (5Y)	0.32
Change from 52-week high	-5.34%
Change from 52-week low	297.96%
Change from all-time high	-76.44%
Change from all-time low	3,233.33%
Change from open	2.63%
Day's gap	-4.52%
Dollar volume	CAD 2,305
High price	CAD 2.00
Low price	CAD 1.90
Monthly RSI	72.37
Open price	CAD 1.90
Position in 52-week range	50%
Previous close	CAD 1.99
Price vs 150-day SMA	66.39%
Price vs 20-day SMA	5.76%
Price vs 200-day SMA	80.83%
Price vs 50-day SMA	7.07%
Relative volume	0.35
RSI	57.69
Sharpe ratio	1.79
Sharpe ratio (3Y)	1.01
Sharpe ratio (5Y)	0.74
Sortino ratio	2.89
Sortino ratio (3Y)	1.73
Sortino ratio (5Y)	1.28
Volume	1.2K
Weekly RSI	71.45
YTD price change	146.91%
YTD total return	146.91%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21.2M
Shares change (QoQ)	0%
Shares held by insiders	0.18%
Shares outstanding	68.9M

Deeper analysis on TSXV/EBM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/EBM report

Is a complete TSXV/EBM research report available?

No complete published report is available for tsxv/EBM (TSXV/EBM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/EBM (TSXV/EBM)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/EBM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/EBM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on TSXV/EBM

Frequently asked questions